Renovascular effects of inorganic nitrate following ischemia-reperfusion of the kidney
Gensheng Zhang,
Huirong Han,
Zhengbing Zhuge,
Fang Dong,
Shan Jiang,
Wenwen Wang,
Drielle D. Guimarães,
Tomas A. Schiffer,
En Yin Lai,
Lucas Rannier Ribeiro Antonino Carvalho,
Ricardo Barbosa Lucena,
Valdir A. Braga,
Eddie Weitzberg,
Jon O. Lundberg,
Mattias Carlstrom
Affiliations
Gensheng Zhang
Dept. of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden; Dept. of Neurobiology, Institute of Neuroscience, NHC and CAMS Key Laboratory of Medical Neurobiology, Zhejiang University School of Medicine, Hangzhou, China
Huirong Han
Dept. of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden; Dept. of Anesthesiology, Shandong Provincial Medicine and Health Key Laboratory of Clinical Anesthesia, Weifang Medical University, Weifang, China
Zhengbing Zhuge
Dept. of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden
Fang Dong
Dept. of Physiology, Zhejiang University School of Medicine, Hangzhou, China
Shan Jiang
Dept. of Physiology, Zhejiang University School of Medicine, Hangzhou, China
Wenwen Wang
Dept. of Pathology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China
Drielle D. Guimarães
Dept. of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden
Tomas A. Schiffer
Dept. of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden
En Yin Lai
Dept. of Physiology, Zhejiang University School of Medicine, Hangzhou, China
Lucas Rannier Ribeiro Antonino Carvalho
Dept. of Biotechnology – Federal University of Paraiba, Joao Pessoa, PB, Brazil
Ricardo Barbosa Lucena
Dept. of Veterinary Sciences – Federal University of Paraiba, Areia, PB, Brazil
Valdir A. Braga
Dept. of Biotechnology – Federal University of Paraiba, Joao Pessoa, PB, Brazil
Eddie Weitzberg
Dept. of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden
Jon O. Lundberg
Dept. of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden
Mattias Carlstrom
Dept. of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden; Corresponding author.Associate Professor of Physiology Department of Physiology and Pharmacology, Karolinska Institutet Solnavägen 9, Biomedicum 5B, 17177 Stockholm, Sweden.
Background: Renal ischemia-reperfusion (IR) injury is a common cause of acute kidney injury (AKI), which is associated with oxidative stress and reduced nitric oxide (NO) bioactivity and increased risk of developing chronic kidney disease (CKD) and cardiovascular disease (CVD). New strategies that restore redox balance may have therapeutic implications during AKI and associated complications. Aim: To investigate the therapeutic value of boosting the nitrate-nitrite-NO pathway during development of IR-induced renal and cardiovascular dysfunction. Methods: Male C57BL/6 J mice were given sodium nitrate (10 mg/kg, i. p) or vehicle 2 h prior to warm ischemia of the left kidney (45 min) followed by sodium nitrate supplementation in the drinking water (1 mmol/kg/day) for the following 2 weeks. Blood pressure and glomerular filtration rate were measured and blood and kidneys were collected and used for biochemical and histological analyses as well as renal vessel reactivity studies. Glomerular endothelial cells exposed to hypoxia-reoxygenation, with or without angiotensin II, were used for mechanistic studies. Results: IR was associated with reduced renal function and slightly elevated blood pressure, in combination with renal injuries, inflammation, endothelial dysfunction, increased Ang II levels and Ang II-mediated vasoreactivity, which were all ameliorated by nitrate. Moreover, treatment with nitrate (in vivo) and nitrite (in vitro) restored NO bioactivity and reduced mitochondrial oxidative stress and injuries. Conclusions: Acute treatment with inorganic nitrate prior to renal ischemia may serve as a novel therapeutic approach to prevent AKI and CKD and associated risk of developing cardiovascular dysfunction.